Evaluation of Human Mesenchymal Stem Cells Differentiation to Neural Cells on Polycaprolactone Nanofiber Scaffolds

AUTHORS

Seyedeh Sara Karimian ORCID 1 , * , Saeid Kaviani ORCID 2 , Masoud Soleimani ORCID 2

1 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

2 Department of Hematology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran

How to Cite: Karimian S S, Kaviani S, Soleimani M. Evaluation of Human Mesenchymal Stem Cells Differentiation to Neural Cells on Polycaprolactone Nanofiber Scaffolds, J Human Gen Genom. Online ahead of Print ; 3(2):e111835. doi: 10.5812/jhgg.111835.

ARTICLE INFORMATION

Journal of Human Genetics and Genomics: 3 (2); e111835
Published Online: January 2, 2021
Article Type: Research Article
Received: December 16, 2020
Accepted: December 21, 2020
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Differentiation of human mesenchymal stem cells (hMSC) to neural cells on Nano-scaffolds is a promising method for the treatment of the damaged nervous system through bionanomaterial-cell transplantation. The hMSC’s multipotential features have been discovered in various tissue engineering researches. This investigation shows the in-vitro development and neural differentiation of hMSC in 3D and 2D environments. The 3D environment which used in this study is nanofibrous polycaprolactone (PCL). The differentiation potential of mesenchymal stem cells (MSCs) to neural cells, on the random polycaprolactone (PCL) nanofibrous scaffolds, and tissue plate was examined. Researches have proved that interaction of extracellular nanofibrous matrix with in-vivo cells, gives mechanical maintenance to the cells and plays a functional role in the control of cellular behaviour. Stem cells are developing as a fundamental tool in the evolution of tissue engineering and regenerative medication. PCL characterization was determined employing scanning electron microscopy (SEM). Agents like, retinoic acid, epidermal growth factor (EGF), fibroblast growth factor (FGF-2), and Ibmx, which they are neural inducing agents, added in DMDM/F12 to differentiate MSCs to neural cells. Reproduction of mesenchymal cells on PCL nanofibrous scaffolds and neural morphology revealed through a scanning electron microscope (SEM) and optical microscope outcomes. The differentiated mesenchymal cells on nanofibrous scaffolds express neural gene markers including; β- tubulin III and Map2 on the day of 14. Our investigation recommends the potential usage of differentiated neural cells from hMSCs on Nano-scaffolds toward the improvement of neural cells. This study conducted in 2011.

1. Background

Repairing the neural damages employing nerve tissue engineering is one of the most promising approaches. In neural tissue engineering, nano-scaffolds use as an extracellular matrix and their efficacy has proved by various researches. Directing role of biomaterial substrates in the differentiation of mesenchymal stem cells (MSCs) has been proven (1, 2). MSCs obtained of bone marrow (BM) are non-hematopoietic stem cells, containing the ability to differentiate into various ectodermal (neural), mesenchymal (adipocyte, chondrocytes), and endodermal (hepatocytes) tissue cells (3). MSC is one of the accessible cell origins of the body, containing the most simple clinical technique of culturing with a high self-regeneration role (4). New researches have demonstrated the capability usages of MSCs obtained of bone marrow, which differentiated on the nano-scaffolds, to tissue renewal (5). Osteoblasts or chondrocytes, which differentiated from MSCs on the 3D nanofiber matrix, were evaluated in the various studies (6, 7). Differentiation of MSCs on the electrospun nanofiber scaffolds has considered in many studies. Scaffolds for tissue regeneration are essential as they provide suitable requirements for cell resistance regeneration and differentiation and tissues' expansion for desired tissue engineering goals (8). Contemporary researches have aimed to build and develop suitable scaffold for tissue reconstruction (9). This examination evaluated the efficacy of polycaprolactone (PCL) nanofiber matrices produced via the phase separation technique as a scaffold for neural tissue reformation (10). PCL presented as a biomaterial for medicine and drug delivery method (11, 12). Furthermore, PCL is a fabricated environment-friendly and non-toxic polymer that has considered a biomaterial for nerve tissue engineering as its convenient form appearance. Although, its low hydrophilicity regularly performs in limited cell adhesion on scaffolds.

An admirable scaffold must produce a strong bond for the cell to attach. Therefore, in this research, the scaffolds were coated by oxygen plasma to improve hydrophilic properties. PCL produces by electrospinning which is a technique used to fabricate polymeric nanofibers applying electrostatic power (13). The hydrophilicity of polycaprolactone (PCL) was improved using O2 plasma treatment. Physicochemical and mechanical properties of random PCL nanofibers scaffolds were evaluated by determining tensile strength and contact angle using a scanning electron microscope (SEM) (14).

2. Objectives

This investigation considers the potential application of MSCs for nerve generation on plasma treated polycaprolactone (P-PCL) nanofibrous scaffolds as a system to improve the neural differentiation leading to neural tissue engineering. In this study, neural gene expression, involving β-Tubulin III and Map2, were examined by immunocytochemistry aim to detect the differentiation of MSCs to neural cells (15).

3. Methods

In this study, Stem Cell Technology Research Center (Tehran- Iran) provided us with human mesenchymal stem cells (hMSCs). Dulbecco’s Modified Eagle’s Medium (DMDM), retinoic acid, EDTA growth factor (EGF), trypsin, Fetal bovine serum (FBS), antibiotics, basic-fibroblast growth factor (FGF) were ordered from Sigma (Sigma-Aldrich, USA). Also, chloroform as well as Polycaprolactone with 8000 molecular weight, and dimethyl formaldehyde (DMF) were ordered from Sigma-Aldrich too.

3.1. Electrospinning of Nanofibers

Chloroform /DMF (9:1), with PCL (8 wt %) which dissolved in is required to perform the electrospinning process. Polymer-solution was loaded to a syringe with needle 21G. A syringe pump was used to feed the polymer solution to the needle tip with a flow speed of 0.5 ml per hour. A high voltage power supply was used to provide the needle with a 25 kV positive voltage. To achieve random nanofibers, a rotating disk with 100 rpm linear rate was applied. The collector was placed in 23 cm from the needle tip. In high-level voltages, Taylor cone was formed, and an electrically jet of the melt (polymer solution) was spattered on the collector. Before using, the nano scaffold was dried overnight.

3.2. Surface Change of Nanofibers

Plasma modification on PCL nanofibrous was conducted employing a plasma cleaning equipment (Germany). Nano-scaffold was located on the chamber of the plasma cleaner. Radiofrequency with electricity power of 30w, following vacuum mode, was applied to plasma vacate.

3.3. In Vitro Culture of Mesenchymal Stem Cell

Eagle's medium (DMEM), which contains antibiotics (6% penicillin/streptomycin ), antifungal (amphotericin-B), and 10% fetal bovine serum (FBS), is a suitable medium to keep mesenchymal stem cells, which were taken from Stem Cell Technology Research Center (Tehran Iran).

Cells nourishing with a new medium every three days, and they were kept in a humid incubator at 37. Trypsin was used to isolate cells from the bottom of the plate before feeding. Neubauer lam was employed to enumerate the cells. For culture MSCs on the scaffold, the cells in the second passage were employed.

3.4. Morphology of Mesenchymal Stem Cell

After culturing the MSCs on tissue plate, the MSCs were isolated from the bottom of the culture plate using trypsin and were cultured on P-PCL nano scaffolds. After seven days of cell feeding, both the MSCs cultured on the scaffolds and the culture plate were prepared for SEM and Optical images. The morphology investigation was conducted for in vitro cultured mesenchymal stem cells on P-PCL scaffold and the plate. PBS was used to rinse the scaffold for twice, as well as, 2.5% glutaraldehyde was used to fix the scaffold for three hours. Scaffold was then dried in 15 minutes with different ethanol concentrations (60%, 70%, 80%, 90%, and 100%). Eventually, the scaffold was coated by gold, and then scrutinized with SEM.

3.5. Neural Induction of MSCs

To neural inducing, human mesenchymal stem cells (hMSCs) developed on electrospun nanofibrous and the plate were induced with substrates, including EGF (10 ng/ml), bFGF (10 ng/ml), retinoic acid (0.5 Mm), and IBMX (0.5 Mm) for 14 days.

3.6. Immunocytochemistry

Induced hMSCs, which were developed on electrospun P-PCL nanofibrous, and also in the plate, were prepared for immunocytochemistry analyses. In the first step, 4% paraformaldehyde was ordered from Sigma-Aldrich, and was used for 20 minutes in 4°C to fix the cells. PBS was used to wash the cells. As well as, Trion- x100 was used for five minutes to block the cells. Then, 5% goat serum was added to the wells containing cells for 45 minutes. In the second step, Primary antibody, anti (1: 500, Bioscience) was added to wells at 4°C overnight. As well as, primary antibody, β-Tubulin (205: 200, Bioscience), was further conducted. In the third step, PBS was applied to rinse the cell-scaffold, and anti-mouse Fluorescein Isothiocyanate secondary antibody (FITC, 1: 500, Sigma) was added to the wells for three hours. Additionally, 4,6-diamidino-2-phenylindole (DAPI 1: 10000 in PBS, Invitrogen, USA) was used for 1 minute to stain the nuclear. The final wash was done with PBS before imagine with the fluorescence microscope (Nikon, Germany). For negative controls of FITC, we considered a cultured cell without primary antibody incubations.

4. Results

During this research, SEM micrograph of electrospun nanofibrous scaffold exhibited beadles, porous nano-scale fibrous construction that developed following suitable spinning situation. Figure 1 shows P-PCL nanofiber scaffold which formed by electrospinning process (Figure 1).

In terms of hydrophilicity, the study of PCL and plasma-treated PCL (p‐PCL) nanofibers contact angle exhibited substantial alteration on the surface characteristics of PCL nanofibers. The fiber diameters of PCL nanofibers with a scale of 400-1500 nm were achieved. After plasma treatment, SEM pictures did not reveal any differences in the surface morphology of PCL nanofiber. Investigations of Contact angle in PCL and P-PCL nanofibers scaffolds disclosed the hydrophilic surface characteristics. These scaffolds were highly hydrophilic and nonabsorbent to water with a contact angle of 134 nm. The PCL treatment with plasma (P-PCL) nanofibrous scaffolds was highly hydrophilic, giving 100% humidity by the water droplet, and with contact angle less than 80°, implying the appearance of the hydrophilic scaffold's surface. Differentiation between PCL and P-PCL random nanofibrous scaffolds' fiber characteristics has been shown in Table 1. The random P-PCL nanofibrous scaffold presented a decrease in mechanical toughness. The random P-PCL nanofibrous scaffold displayed a reduction in mechanical toughness. It is suggested that the hydrophilicity of P-PCL scaffold lowered their mechanical toughness. tensile strength of PCL and P-PCL nanofibers has shown in Table 2.

Table 1. Differentiation Between PCL and P-PCL Nanofibers
PropertiesPCLP-PCL
Porosity9999
Contact angle 134< 80
wettabilityHighly hydrophilicHighly Hydrophilic
Table 2. Tensile Strength in Poly Caprolactone (PCL) and Plasma-Polycaprolactone (P-PCL) Nanofibers
Nanofiber scaffoldsTensile stressTensile strain
Random PCL 1.85363.79
Random P-PCL1.68247-39

4.1. Morphological Studies of Mesenchymal Stem Cells

Figure 2 reveals typical morphology of culture mesenchymal stem cells on plate (2D environment) and P-PCL scaffolds (3D environment) after one day of cell culture. The image of MSCs cultured on the plate was taken by an optical microscope, and the image of MSCs cultured on the nano scaffold was taken by an electron microscope. Mesenchymal stem cells have a flat fibroblast-like form. Figure 3 shows a typical morphology of neural cells differentiated from MSCs using neural induction medium. Differentiation of MSCs was conducted on both 2D environment (plate) and 3D environment (PCL nano scaffold).

Figure 2. (a) Optical image of MSCs cultured on the plate after one day. (b) SEM image of MSCs cultured on the P-PCL after one day.
Figure 3. (a) Optical image of neural cells differentiated from MSCs on the plate. (b) SEM image of neural cells differentiated from MSCs on the P-PCL nano scaffold.

4.2. Immunostaining of Cultured Scaffolds

Figure 4 shows the Immunocytochemistry outcomes of differentiated MSCs on the P-PCL nano scaffold and also on plate. Differentiated MSCs were immune stained aim to detect β-tubulin III and Map-2 genes which they are neural gene markers. Expression of β-tubulin III and Map-2 genes were observed in cytoplasm and nucleus of neural cells differentiated from MSCs on the P-PCL scaffold. Also, the expression of β-tubulin III and Map-2 genes were observed in cytoplasm and nucleus of neural cells differentiated from MSCs on the plate. These neural gene markers were not observed in the control culture containing non-differentiated MSCs.The bulk of differentiated MSCs displays bipolar configuration with two elongated neuritides. The differentiated MSCs on the random nanofibers were determined with multiple processes. These outcomes recommend that random nanofibers are not able of managing the orientation of neurons.

Figure 4. Fluorescence microscopic images of differentiated MSCs. (a) The cells cultured on the plate after 15 days treatment with neural inducing medium, evaluated for β-tubulin III and Map2 genes expression. (b) The cells cultured on the P-PCL nano scaffold after 15 days treatment with neural inducing medium, evaluated for β-tubulin III and Map2 genes expression. To detecting the neural cell's nuclei, co-staining by 4,6-diamidino-2-phenylindole (blue) was conducted.

5. Discussion

Stem cell therapy is a promising strategy for the healing of the injured CNS. MSCs have been examined in many studies aim to stem cell-based transplantation in restoring damaged spinal cord (16, 17) because of easy access, low immunogenicity paracrine (18, 19) and immune-modulatory effects (20). MSCs of bone marrow operate an essential function in tissue reconstruction. Though different from an embryonic stem cells (ESCs) in some features. MSCs have self-renewing ability and multilineage differentiation but are free from ethical concerns and tumorigenesis danger (21). Consequently, these cells are more suitable than other cell references for medical usages. Illustrating the impacts of mesenchymal stem cells on peripheral nerve rehabilitation have recommended by numerous desirable mechanisms. Generally, mesenchymal stem cells build a desirable condition for nerve rehabilitation. They influence nerve reconstruction development by cell transplantation induction, growth factors production, construction of extracellular matrix, anti-inflammatory release as well as immune system regulators (22). Mesenchymal stem cells are recommended to differentiate into bone, cartilage, cardiac myocytes, and neural cultures (23, 24). The neural differentiation of MSCs was notified as a method of cell therapy.

A biocompatible scaffold, useful cell source, and suitable biochemical circumstances are essential for improving biological replacements that can repair, sustain, or enhance tissue function (5). The idea of employing the MSC-bio nanomaterial method for transplantation in nervous system damage was examined (25, 26). This method includes the transplantation of electrospun polymeric nanofibrous scaffolds, including differentiated neuronal cell from MSCs. Electrospun nanofibers structures give construction resistance, architectural direction and facilities in cell connection to reply desirable response to the in-vivo alterations to improve the ECM (27). The P-PCL nano-dimensional scaffold, which mimics the ECM, can improve tissue reformation in vitro comparable to how the original ECM effects.

In this research we determined that the P-PCL nanofibers assembled by electrospinning have a possible utilization in nerve tissue engineering.

Different nanofibrous scaffolds can be applied for the formation of nanofibrous scaffolds for nerve reconstruction. PCL has been widely utilized for tissue engineering due to its tremendous tensile strength, non-toxic creation, and biodegradability (28). However, its hydrophilic characteristic is favorable for in vitro cell culture plasma processing. Plasma treatment is an efficient technique for improving surface hydrophilicity of polymers by groups containing oxygen (OH, COOH.) (29). Plasma surface treatment of scaffolds with N2, O2, and NH3, which have affirmed in several investigations, gives the polymer’s surface further hydrophilic, further polar, and further bio-adhesive (30). In this research, nanofibrous surface treatment with plasma was an effective method to develop PCL nanofibers hydrophilic quality.

Our study outcomes recommend the ability of P-PCL nanofibrous scaffold structure which promote the differentiation of MSCs to neural cells (31). Methods for differentiation of neural cells from embryonic stem cells (ESCs) have also been issued in several studies (32, 33). However, the ability of ESCs, concerning neural differentiation in comparison to hematopoietic and mesenchymal cell lines is weak (34).

The β-tubulin and Map2 are neural gene markers which were recognized by immunocytochemistry in neuronal cells differentiated from MSCs on P-PCL nanofibers after 14 days of cell culture, indicating the neural cells differentiated of MSCs. Morphological, as well as immunological assessment, affirmed the MSCs differentiation into nerve cells on the nano-scaffolds. We have shown the morphological and genes expression of neuronal cells created from MSCs, in fabricated nanofibrous. The molecular mechanisms for longe-time neuronal differentiation engaged in the development of nerve system have not yet fully understood, and more researches are needed to explain the nerve system development.

5.1. Conclusion

Neuronal differentiation of MSCs can be supported with suitable chemical and biological properties nanostructures. Neural cells on electrospun nanofibrous scaffold differentiated from BM could be a promising method for transplantation following nerve reconstruction in the place of damage. In this research, the P-PCL nanofibrous scaffold were built by electrospinning. They were affirmed as the proper substrates for the differentiation of MSCs to the neuronal cells using neuronal factors induction. The differentiation of MSCs on P-PCL nanofibrous scaffold exhibited multipolar elongation and β-tubulin and Map 2 genes expression, two standard gene markers of neural cells.

Acknowledgements

Footnotes

References

  • 1.

    Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008;60(2):184-98. doi: 10.1016/j.addr.2007.08.041. [PubMed: 18045729]. [PubMed Central: PMC2271038].

  • 2.

    Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials. 2003;24(24):4353-64. doi: 10.1016/s0142-9612(03)00339-9.

  • 3.

    Krampera M, Marconi S, Pasini A, Galie M, Rigotti G, Mosna F, et al. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone. 2007;40(2):382-90. doi: 10.1016/j.bone.2006.09.006. [PubMed: 17049329].

  • 4.

    Chen Y, Teng FY, Tang BL. Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: progress and uncertainties. Cell Mol Life Sci. 2006;63(14):1649-57. doi: 10.1007/s00018-006-6019-5. [PubMed: 16786223].

  • 5.

    Shih YR, Chen CN, Tsai SW, Wang YJ, Lee OK. Growth of mesenchymal stem cells on electrospun type I collagen nanofibers. Stem Cells. 2006;24(11):2391-7. doi: 10.1634/stemcells.2006-0253. [PubMed: 17071856].

  • 6.

    Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials. 2006;27(22):4079-86. doi: 10.1016/j.biomaterials.2006.03.030. [PubMed: 16600365].

  • 7.

    Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials. 2005;26(6):599-609. doi: 10.1016/j.biomaterials.2004.03.005. [PubMed: 15282138].

  • 8.

    Kim BS, Baez CE, Atala A. Biomaterials for tissue engineering. World J Urol. 2000;18(1):2-9. doi: 10.1007/s003450050002. [PubMed: 10766037].

  • 9.

    Eltom A, Zhong G, Muhammad A. Scaffold Techniques and Designs in Tissue Engineering Functions and Purposes: A Review. Adv Mater Sci Eng. 2019;2019:1-13. doi: 10.1155/2019/3429527.

  • 10.

    Prabhakaran MP, Venugopal JR, Chyan TT, Hai LB, Chan CK, Lim AY, et al. Electrospun biocomposite nanofibrous scaffolds for neural tissue engineering. Tissue Eng Part A. 2008;14(11):1787-97. doi: 10.1089/ten.tea.2007.0393. [PubMed: 18657027].

  • 11.

    Lemmouchi Y, Schacht E. Preparation and in vitro evaluation of biodegradable poly(ϵ-caprolactone-co-d,l lactide)(X-Y) devices containing trypanocidal drugs. J Control Release. 1997;45(3):227-33. doi: 10.1016/s0168-3659(96)01569-6.

  • 12.

    Ye WP, Du FS, Jin WH, Yang JY, Xu Y. In vitro degradation of poly(caprolactone), poly(lactide) and their block copolymers: influence of composition, temperature and morphology. React Funct Polym. 1997;32(2):161-8. doi: 10.1016/s1381-5148(96)00081-8.

  • 13.

    Ramakrishna S, Fujihara K, Teo W, Lim T, Ma Z. An Introduction to Electrospinning and Nanofibers. World Scientific; 2005. doi: 10.1142/5894.

  • 14.

    Jahani H, Jalilian FA, Wu CY, Kaviani S, Soleimani M, Abbasi N, et al. Controlled surface morphology and hydrophilicity of polycaprolactone toward selective differentiation of mesenchymal stem cells to neural like cells. J Biomed Mater Res A. 2015;103(5):1875-81. doi: 10.1002/jbm.a.35328. [PubMed: 25203786].

  • 15.

    Tanapat P. Neuronal Cell Markers. Mater Method. 2013;3:96. doi: 10.13070/mm.en.3.196.

  • 16.

    Tropel P, Platet N, Platel JC, Noel D, Albrieux M, Benabid AL, et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells. 2006;24(12):2868-76. doi: 10.1634/stemcells.2005-0636. [PubMed: 16902198].

  • 17.

    Dong L, Hao H, Han W, Fu X. The role of the microenvironment on the fate of adult stem cells. Sci China Life Sci. 2015;58(7):639-48. doi: 10.1007/s11427-015-4865-9. [PubMed: 25985755].

  • 18.

    Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838-43. doi: 10.1182/blood.v99.10.3838. [PubMed: 11986244].

  • 19.

    Jiang Y, Jahagirdar BN, Reinhardt R, Schwartz RE, Keene C, Ortiz-Gonzalez XR, et al. Erratum: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2007;447(7146):880-1. doi: 10.1038/nature05812.

  • 20.

    Okano H. Neural stem cells and strategies for the regeneration of the central nervous system. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(4):438-50. doi: 10.2183/pjab.86.438. [PubMed: 20431266]. [PubMed Central: PMC3417805].

  • 21.

    Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-7. doi: 10.1126/science.284.5411.143. [PubMed: 10102814].

  • 22.

    Kaka G, Arum J, Sadraie SH, Emamgholi A, Mohammadi A. Bone Marrow Stromal Cells Associated with Poly L-Lactic-Co-Glycolic Acid (PLGA) Nanofiber Scaffold Improve Transected Sciatic Nerve Regeneration. Iran J Biotechnol. 2017;15(3):149-56. doi: 10.15171/ijb.1576. [PubMed: 29845063]. [PubMed Central: PMC5811061].

  • 23.

    Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2):247-56. doi: 10.1006/exnr.2000.7389. [PubMed: 10915564].

  • 24.

    Deng W, Obrocka M, Fischer I, Prockop DJ. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun. 2001;282(1):148-52. doi: 10.1006/bbrc.2001.4570. [PubMed: 11263984].

  • 25.

    Prabhakaran MP, Venugopal JR, Ramakrishna S. Mesenchymal stem cell differentiation to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. Biomaterials. 2009;30(28):4996-5003. doi: 10.1016/j.biomaterials.2009.05.057. [PubMed: 19539369].

  • 26.

    Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials. 2003;24(12):2077-82. doi: 10.1016/s0142-9612(02)00635-x.

  • 27.

    Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61(4):364-70. doi: 10.1002/1097-4547(20000815)61:4<364::aid-jnr2>3.0.co;2-c.

  • 28.

    Park K, Ju YM, Son JS, Ahn KD, Han DK. Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts. J Biomater Sci Polym Ed. 2007;18(4):369-82. doi: 10.1163/156856207780424997. [PubMed: 17540114].

  • 29.

    Yang J, Bei J, Wang S. Improving cell affinity of poly(D,L-lactide) film modified by anhydrous ammonia plasma treatment. Polym Adv Technol. 2002;13(3-4):220-6. doi: 10.1002/pat.177.

  • 30.

    Ryu GH, Yang W, Roh H, Lee I, Kim JK, Lee GH, et al. Plasma surface modification of poly (d,l-lactic-co-glycolic acid) (65/35) film for tissue engineering. Surf Coat Technol. 2005;193(1-3):60-4. doi: 10.1016/j.surfcoat.2004.07.062.

  • 31.

    Wenisch S, Trinkaus K, Hild A, Hose D, Heiss C, Alt V, et al. Immunochemical, ultrastructural and electrophysiological investigations of bone-derived stem cells in the course of neuronal differentiation. Bone. 2006;38(6):911-21. doi: 10.1016/j.bone.2005.10.021. [PubMed: 16418015].

  • 32.

    Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, et al. Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity. Neuron. 2000;28(1):31-40. doi: 10.1016/s0896-6273(00)00083-0.

  • 33.

    Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol. 2003;21(10):1200-7. doi: 10.1038/nbt870. [PubMed: 14502203].

  • 34.

    Zhou JM, Chu JX, Chen XJ. An improved protocol that induces human embryonic stem cells to differentiate into neural cells in vitro. Cell Biol Int. 2008;32(1):80-5. doi: 10.1016/j.cellbi.2007.08.015. [PubMed: 17945517].

  • Copyright © 2021, Journal of Human Genetics and Genomics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: